Suivre
Luciana Caravatta
Luciana Caravatta
Radiotherapy Oncology Unit, SS Annunziata Hospital, Via dei Vestini 1, 66100, Chieti. Italy
Adresse e-mail validée de asl2abruzzo.it
Titre
Citée par
Citée par
Année
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer
AG Morganti, M Massaccesi, G La Torre, L Caravatta, A Piscopo, ...
Annals of surgical oncology 17, 194-205, 2010
1782010
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer
S Cilla, L Caravatta, V Picardi, D Sabatino, G Macchia, C Digesù, ...
Clinical Oncology 24 (4), 261-268, 2012
742012
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience
L Caravatta, G Macchia, GC Mattiucci, A Sainato, NLV Cernusco, ...
Radiation oncology 9, 1-9, 2014
692014
Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: a population study on 2094 patients
G Macchia, MA Gambacorta, C Masciocchi, G Chiloiro, G Mantello, ...
Clinical and translational radiation oncology 4, 8-14, 2017
662017
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 …
V Valentini, MA Gambacorta, F Cellini, C Aristei, C Coco, B Barbaro, ...
Radiotherapy and Oncology 134, 110-118, 2019
532019
PI3‐K/Akt‐dependent activation of cAMP‐response element‐binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL
L Caravatta, S Sancilio, V Di Giacomo, R Rana, A Cataldi, R Di Pietro
Journal of cellular physiology 214 (1), 192-200, 2008
482008
Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study
L Caravatta, GDA Padula, G Macchia, G Ferrandina, P Bonomo, ...
International Journal of Radiation Oncology* Biology* Physics 83 (5), e627-e631, 2012
402012
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer
L Caravatta, G Sallustio, F Pacelli, GDA Padula, F Deodato, G Macchia, ...
Radiation Oncology 7, 1-10, 2012
372012
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible?
F Deodato, S Cilla, M Gabriella, M Massaccesi, E Ippolito, L Caravatta, ...
Tumori Journal 98 (4), 441-444, 2012
362012
Performance of diffusion-weighted magnetic resonance imaging at 3.0 T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative …
A Delli Pizzi, R Cianci, D Genovesi, G Esposito, M Timpani, A Tavoletta, ...
Abdominal radiology 43, 2221-2230, 2018
352018
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study
L Caravatta, GDA Padula, V Picardi, G Macchia, F Deodato, ...
Acta Oncologica 50 (8), 1151-1157, 2011
342011
Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation
R Di Pietro, V di Giacomo, L Caravatta, S Sancilio, RA Rana, A Cataldi
Journal of cellular biochemistry 100 (4), 1070-1079, 2007
342007
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial
M Massaccesi, S Cilla, F Deodato, C Digesu, G Macchia, L Caravatta, ...
Anticancer Research 33 (6), 2785-2789, 2013
312013
Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer
A Delli Pizzi, D Caposiena, D Mastrodicasa, S Trebeschi, D Lambregts, ...
Abdominal radiology 44, 3595-3605, 2019
302019
Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: a dose-escalation study
L Caravatta, V Picardi, R Tambaro, GDA Padula, G Macchia, F Deodato, ...
American Journal of Clinical Oncology 35 (5), 424-431, 2012
292012
Basics and frontiers on pancreatic cancer for radiation oncology: target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines
F Cellini, A Arcelli, N Simoni, L Caravatta, M Buwenge, A Calabrese, ...
Cancers 12 (7), 1729, 2020
272020
Reproducibility of rectal tumor volume delineation using diffusion-weighted MRI: Agreement on volumes between observers
C Rosa, L Caravatta, AD Pizzi, M Di Tommaso, R Cianci, L Gasparini, ...
Cancer/Radiothérapie 23 (3), 216-221, 2019
272019
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2)
F Deodato, S Cilla, G Macchia, G Torre, L Caravatta, G Mariano, ...
Clinical oncology 26 (12), 748-756, 2014
252014
Regulation of CREB activation by p38 mitogen activated protein kinase during human primary erythroblast differentiation
V Di Giacomo, S Sancilio, L Caravatta, RA Rana, R Di Pietro, A Cataldi
International Journal of Immunopathology and Pharmacology 22 (3), 679-688, 2009
252009
Short-course regimen of palliative radiotherapy in complicated bone metastases: a phase i–ii study (SHARON Project)
J Capuccini, G Macchia, E Farina, M Buwenge, D Genovesi, L Caravatta, ...
Clinical & experimental metastasis 35, 605-611, 2018
202018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20